Clinical Trials Directory

Trials / Conditions / Vaginal Carcinoma

Vaginal Carcinoma

12 registered clinical trials studyying Vaginal Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingVaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
NCT07407647
Ohio State University Comprehensive Cancer CenterPhase 2
RecruitingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog
NCT07118176
Jonsson Comprehensive Cancer CenterPhase 1
RecruitingHPV Vaccine, Imiquimod, and Metformin Combination Trial
NCT06686043
Baylor College of MedicinePhase 2
CompletedGynecological Sentinel Lymph Nodes CEUS
NCT05105087
Thomas Jefferson UniversityEARLY_Phase 1
Active Not RecruitingChanges in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiatio
NCT04713618
Ohio State University Comprehensive Cancer Center—
TerminatedTesting AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Canc
NCT03345784
National Cancer Institute (NCI)Phase 1
CompletedFractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivo
NCT03372720
Ohio State University Comprehensive Cancer CenterN/A
WithdrawnNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High
NCT03220009
National Cancer Institute (NCI)Phase 2
CompletedBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NCT03180294
NRG OncologyPhase 2
Active Not RecruitingTesting the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) Duri
NCT02466971
National Cancer Institute (NCI)Phase 3
TerminatedPeer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and The
NCT02412124
City of Hope Medical CenterN/A
Active Not RecruitingLongitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer
NCT00791635
M.D. Anderson Cancer Center—